Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2025-12-24 @ 6:40 PM
NCT ID:
NCT03238157
Eligibility Criteria:
Inclusion Criteria:
* Primary uveal melanoma
* Primary treatment with plaque brachytherapy
* Baseline visual acuity 20/200 or better
* Posterior tumor margin \>1.50 mm from the center of the macula
* Posterior tumor margin \> 1.50 mm from the closest disc margin
* Calculated total dose to center of the macula \>40 Gy
Exclusion Criteria:
* Iris melanoma
* Opaque media
* less than 21 years of age
* Inability to give consent
* Positive pregnancy test
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT03238157
Study Brief:
Protocol Section:
NCT03238157